| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 519.2K | $12.39M | - | |
| CFO | 226.6K | $5.41M | - | |
| Other | 167.0K | $3.99M | - | |
| Other | 133.2K | $3.18M | - | |
| Other | 108.9K | $2.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2019 | Christian Klemt59 | Chief Accounting Officer | Sell | 5,739 | $27.91 | $160,175.49 | -12.5% | |
| Dec 3, 2018 | Philip Astley-Sparke47 | Director | Sell | 5,000 | $30.39 | $151,950.00 | -17.7% | |
| Jun 6, 2018 | Steven Zelenkofske | Chief Medical Officer | Sell | 23,929 | $37.14 | $888,723.06 | -13.0% | |
| Mar 15, 2018 | Matthew C Kapusta64 | CEO, CFO, Managing Director | Sell | 39,169 | $21.72 | $850,750.68 | -8.2% | |
| Jan 29, 2018 | David Schaffer86 | Director | Sell | 2,878 | $18.53 | $53,329.34 | -15.8% | |
| Jan 29, 2018 | Jack Kaye52 | Director | Sell | 2,878 | $18.53 | $53,329.34 | -18.2% | |
| Jan 29, 2018 | Philip Astley-Sparke47 | Director | Sell | 6,540 | $18.53 | $121,186.20 | -18.8% | |
| Jan 29, 2018 | Sander van Deventer | Chief Scientific Officer | Sell | 5,985 | $18.53 | $110,902.05 | -19.3% | |
| Jan 29, 2018 | Paula Soteropoulos75 | Director | Sell | 2,878 | $18.53 | $53,329.34 | -13.8% | |
| Jan 4, 2018 | Matthew C Kapusta64 | CEO, CFO, Managing Director | Sell | 21,690 | $19.87 | $431,069.23 | -4.6% |